Evidence map›Paper›PMID 33755710›Full record

ArticlePloS one2021

Phage susceptibility testing and infectious titer determination through wide-field lensless monitoring of phage plaque growth.

Prisca Perlemoine, Pierre R Marcoux, Emmanuel Picard, Emmanuel Hadji, Marc Zelsmann, Grégoire Mugnier, Aurélie Marchet, Grégory Resch, Larry O'Connell, Eric Lacot

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Phages produce persisters.Microbial biotechnology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Rapid hydrogel-based phage susceptibility test for pathogenic bacteria.Frontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Prisca PerlemoineDepartment of Microtechnologies for Biology and Health, LETI, CEA, University Grenoble Alpes, Grenoble, France.ORCID 0000-0001-7490-3622
Pierre R MarcouxDepartment of Microtechnologies for Biology and Health, LETI, CEA, University Grenoble Alpes, Grenoble, France.
Emmanuel PicardSINAPS, PHELIQS, DEPHY, IRIG, DRF, CEA, University Grenoble Alpes, Grenoble, France.
Emmanuel HadjiSINAPS, PHELIQS, DEPHY, IRIG, DRF, CEA, University Grenoble Alpes, Grenoble, France.
Marc ZelsmannLTM-Micro and Nanotechnologies for Health, CNRS, CEA, University Grenoble Alpes, Grenoble, France.
Grégoire MugnierLTM-Micro and Nanotechnologies for Health, CNRS, CEA, University Grenoble Alpes, Grenoble, France.
Aurélie MarchetDepartment of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland.
Grégory ReschDepartment of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland.
Larry O'ConnellSyMMES, IRIG, DRF, CEA, University Grenoble Alpes, Grenoble, France.ORCID 0000-0002-9551-3444
Eric LacotLaboratoire Interdisciplinaire de Physique, CNRS UMR 5588, University Grenoble Alpes, St Martin d'Hères, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growing number of drug-resistant bacterial infections worldwide is driving renewed interest in phage therapy. Based on the use of a personalized cocktail composed of highly specific bacterial viruses, this therapy relies on a range of tests on agar media to determine the most active phage on a given bacterial target (phage susceptibility testing), or to isolate new lytic phages from an environmental sample (enrichment of phage banks). However, these culture-based techniques are still solely interpreted through direct visual detection of plaques. The main objective of this work is to investigate computer-assisted methods in order to ease and accelerate diagnosis in phage therapy but also to study phage plaque growth kinetics. For this purpose, we designed a custom wide-field lensless imaging device, which allows continuous monitoring over a very large area sensor (3.3 cm2). Here we report bacterial susceptibility to Staphylococcus aureus phage in 3 hr and estimation of infectious titer in 8 hr 20 min. These are much shorter time-to-results than the 12 to 24 hours traditionally needed, since naked eye observation and counting of phage plaques is still the most widely used technique for susceptibility testing prior to phage therapy. Moreover, the continuous monitoring of the samples enables the study of plaque growth kinetics, which enables a deeper understanding of the interaction between phage and bacteria. Finally, thanks to the 4.3 μm resolution, we detect phage-resistant bacterial microcolonies of Klebsiella pneumoniae inside the boundaries of phage plaques and thus show that our prototype is also a suitable device to track phage resistance. Lensless imaging is therefore an all-in-one method that could easily be implemented in cost-effective and compact devices in phage laboratories to help with phage therapy diagnosis.

Indexed as

Image Processing, Computer-AssistedLensesBacteriaBacteriophagesKineticsTime Factors

Identifiers

PMID33755710
PMCPMC7987195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.